The Asia Pacific region, particularly China, Japan, and South Korea, is also witnessing significant growth in the biopharmaceutical third-party logistics market. Rapid industrialization, increasing investments in healthcare infrastructure, and rising GDP in these countries have contributed to the expansion of the market in this region.
In Europe, countries such as the United Kingdom, Germany, and France are key players in the biopharmaceutical third-party logistics market. The presence of major pharmaceutical companies, strong regulatory frameworks, and advancements in healthcare technology are driving growth in Europe.